Clinical study for the improvement of the onset delay of SSRIs antidepressants by ''Shu-Gan Tiao-Shen'' remedy of Acupuncture
- Conditions
- Moderate DepressionF32.100
- Registration Number
- ITMCTR2000003184
- Lead Sponsor
- The Second Affiliated Hospital of Guangzhou University of traditional Chinese medicine (Guangdong Hospital of traditional Chinese Medicine)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. The scores of HAMD-17 are higher than 17 and less than 24 in the patients who meet the ICD-10 diagnostic criteria of depressive episode and are initially diagnosed as moderate depressive episode;
2. Patients aged 18-55 years;
3. Patients who have no history of serious brain organic diseases and body diseases, and can understand the scale content and cooperate with the treatment;
4. Patients without previous mental history;
5. Right handed patients;
6. Patients who do not drink caffeinated drinks, drink or smoke during the intervention period;
7. Patients with the first moderate depression attack who did not use SSRIs antidepressants or drugs that affect cognitive function within 4 weeks or who stopped using other antidepressants for more than 1 week;
8. Patients who voluntarily participate in clinical research and agree to sign informed consent.
1. Patients with organic mental disorders or depression related to psychoactive substances and non addictive substances;
2. Patients with other family history of mental illness, such as dementia, schizophrenia, mania, addiction, etc;
3. Patients who have a history of mania or hypomania;
4. Patients who have recently taken drugs that may cause emotional disorders, such as blood benefit equality;
5. Pregnant or lactating women;
6. Patients with vision and hearing impairment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HAMD-17;
- Secondary Outcome Measures
Name Time Method Evaluation of acupuncture expectation;BDI-13;